Pharmaceuticals & Health Products

More from the Series

Blog Post

Understanding the Impact Of COVID-19 On Essential Medicine Supply Chains

June 17, 2020
This blog outlines some of the challenges in the global supply of medicines and introduces a methodology that will enable countries to spot early challenges in supply.
CGD NOTE

Aggregating Demand for Pharmaceuticals is Appealing, but Pooling Is Not a Panacea

May 01, 2019
As low- and middle-income countries shift away from donor support, their challenge will be finding a way to aggregate demand in order to achieve the benefits that the pooled purchasing arrangements of vertical health programs now provide. As a first step in tackling this challenge, much can be learn...
WORKING PAPER

Who Benefits from Pharmaceutical Price Controls? Evidence from India - Working Paper 509

April 23, 2019
With the goal of driving down drug costs, governments across the globe have instituted various forms of pharmaceutical price control policies. In this paper, we examine the theoretical and empirical effects of one implementation of pharmaceutical price controls, in which the Indian government placed...

The Future of Global Health Procurement: Background Research

April 15, 2019
Background research and resources from CGD's growing porfolio on the future of global health procurement.